Rapport Therapeutics, Inc. Common Stock (NASDAQ: RAPP) last traded at $30.15, down 1.63% on the session. The quote above updates while this page is open; the figures below are drawn from Rapport Therapeutics, Inc. Common Stock’s own filings and are restated only when a new one is published.
Rapport Therapeutics, Inc. Common Stock trades on NASDAQ under the ticker RAPP. Its market capitalisation is $1.45 billion.
Valuation measures for Rapport Therapeutics, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $1.45B |
|---|---|
| Enterprise value | $1.42B |
| Price / book | 3.42 |
| Beta | 1.31 |
Trailing-twelve-month figures tagged in Rapport Therapeutics, Inc. Common Stock's XBRL filings with the SEC.
| Net income (TTM) |
|---|
| -$137.16M |
| EPS (TTM) | -$3.04 |
|---|
| Return on equity | -32.43% |
|---|
| Cash | $63.61M |
|---|
Range and volume for RAPP over the past 52 weeks.
| 52-week high | $52.93 |
|---|---|
| 52-week low | $23.75 |
| Volume | 127.1K |
| Average volume | 352.0K |
| Previous close | $30.65 |
Invest a chosen dollar amount in Rapport Therapeutics, Inc. Common Stock with fractional shares.
Start investingCreate an account
Investing involves risk, including possible loss of principal. Nothing here is investment advice or a recommendation to buy or sell RAPP.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.